{
  "id": 17189548,
  "title": "Aspen Neuroscience lands $141M IPO, while Bambusa secures $169M",
  "url": "https://urgent.news/2026/10/30/aspen-neuroscience-lands-141m-ipo-while-bambusa-secures-169m",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-30T06:11:31.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/aspen-neuroscience-lands-141m-ipo-while-bambusa-secures-169m/"
  },
  "original_language": "en",
  "account": null,
  "summary": "A Parkinson's cell therapy biotech and an I&I startup from former BioNTech leaders will join the public markets on Friday, extending a sizzling IPO streak for drug developers. Aspen Neuroscience will collect ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Aspen Neuroscience prices IPO at $15 per share",
        "url": "https://urgent.news/2026/10/30/aspen-neuroscience-prices-ipo-at-15-per-share",
        "published": "2026-10-30T02:16:30.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}